Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Larrey

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Presse Medicale (Paris, France : 1983)|May 8, 2003
[From hepatic steatosis due to obesity to cirrhosis, in the absence of alcoholic intoxication]Dominique Larrey
Seminars in Liver Disease|May 23, 2002
Epidemiology and individual susceptibility to adverse drug reactions affecting the liverDominique Larrey
Frontiers in Pharmacology|January 11, 2020
Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and ValidationLucy Meunier, Dominique Larrey
Annals of Hepatology|February 17, 2020
Chemotherapy-associated steatohepatitisLucy Meunier, Dominique Larrey
International Journal of Molecular Sciences|January 8, 2023
Hepatotoxicity of Drugs Used in Multiple Sclerosis, Diagnostic Challenge, and the Role of HLA Genotype SusceptibilityLucy Meunier, Dominique Larrey
Annals of Hepatology|February 23, 2018
Recent Advances in Hepatotoxicity of Non Steroidal Anti-Inflammatory DrugsLucy Meunier, Dominique Larrey
European Journal of Gastroenterology & Hepatology|January 28, 2005
Drug-induced acute liver failureDominique Larrey, Georges-Philippe Pageaux
Gastroenterologie Clinique Et Biologique|October 30, 2007
[Chronic hepatitis C: management of side effects of treatment]Dominique Larrey, Patrice Couzigou, Jacques Denis
World Journal of Gastroenterology|November 18, 2015
Hepatitis C virus infection: Are there still specific problems with genotype 3?Claire Gondeau, Georges Philippe Pageaux, Dominique Larrey
Annals of Hepatology|June 15, 2017
Liver Biopsy in Chronic Liver Diseases: Is There a Favorable Benefit: Risk Balance?Dominique Larrey, Lucy Meunier, José Ursic-Bedoya
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Presse Medicale (Paris, France : 1983)|May 8, 2003
[From hepatic steatosis due to obesity to cirrhosis, in the absence of alcoholic intoxication]Dominique Larrey
Seminars in Liver Disease|May 23, 2002
Epidemiology and individual susceptibility to adverse drug reactions affecting the liverDominique Larrey
Frontiers in Pharmacology|January 11, 2020
Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and ValidationLucy Meunier, Dominique Larrey
Annals of Hepatology|February 17, 2020
Chemotherapy-associated steatohepatitisLucy Meunier, Dominique Larrey
International Journal of Molecular Sciences|January 8, 2023
Hepatotoxicity of Drugs Used in Multiple Sclerosis, Diagnostic Challenge, and the Role of HLA Genotype SusceptibilityLucy Meunier, Dominique Larrey
Annals of Hepatology|February 23, 2018
Recent Advances in Hepatotoxicity of Non Steroidal Anti-Inflammatory DrugsLucy Meunier, Dominique Larrey
European Journal of Gastroenterology & Hepatology|January 28, 2005
Drug-induced acute liver failureDominique Larrey, Georges-Philippe Pageaux
Gastroenterologie Clinique Et Biologique|October 30, 2007
[Chronic hepatitis C: management of side effects of treatment]Dominique Larrey, Patrice Couzigou, Jacques Denis
World Journal of Gastroenterology|November 18, 2015
Hepatitis C virus infection: Are there still specific problems with genotype 3?Claire Gondeau, Georges Philippe Pageaux, Dominique Larrey
Annals of Hepatology|June 15, 2017
Liver Biopsy in Chronic Liver Diseases: Is There a Favorable Benefit: Risk Balance?Dominique Larrey, Lucy Meunier, José Ursic-Bedoya
Pageof 14